MRNA stock experienced significant volatility and an overall downward trend from early 2023 to early 2025. After peaking near $195 in January 2023, the price declined to lows around $70-$80 by late 2023.

A strong rebound saw the stock briefly recover to about $165 by mid-2024. However, it subsequently underwent a sharp and sustained decline, reaching its lowest point on the chart.

As of early 2025, MRNA is trading around $40-$45, representing a substantial decrease over the two-year period depicted.